November 27, 2019 07:42 AM ESTUpdated 10:23 AM
R&D

Ko­re­an biotech’s shares soar for a 'best of ES­MO' award it nev­er re­ceived

Jason Mast

Editor

A Ko­re­an biotech an­nounced in Oc­to­ber it had earned recog­ni­tion on a “Best of ES­MO 2019” list – a fact that turned out to be …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times